Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Purpose Canadian Financial Income Series A T.BNC

The fund seeks to provide shareholders with (i) long-term capital appreciation through investment in a portfolio of Canadian Banks (defined below) (up to 70% on an equal weighted basis) and Canadian Insurance Companies (defined below) (up to 30% on an equal weighted basis) and (ii) monthly distributions.To achieve its investment objectives, the fund will invest primarily in equity securities of Canadian Banks (up to 70% on an equal weighted basis) and to a lesser extent Canadian Insurance Companies (up to 30% on an equal weighted basis). portfolio of Canadian Banks (defined below) (up to 70% on an equal weighted basis) and CanadianInsurance Companies (defined below) (up to 30% on an equal weighted basis) and (ii) monthlydistributions.


TSX:BNC - Post by User

Post by NearlyDoneon Aug 26, 2016 2:06pm
340 Views
Post# 25181249

MCNA Value - Worthless you should know

MCNA Value - Worthless you should know
some people invested here for the cattle vaine but I know many held on through the problems hoping for success with the Baldder Cancer treatment MCNA. You have to wade through a lot of really gloomy and depressing incomplete N Releases to find anything positive about MCNA but really not that far calendar-wise. In November of last year a very comprehensive presentation was provided at their FDA advisory comission by 2 very senior and well respected American urologists, Dr. Kamat and Dr. O'Donnel. Both Dr's were convincing in their argument for MCNA's approval <This was the meeting where Telesta's chief clinical officer did not speak>. so compelling were they that the majority of practicing Urologists on the panel voted to support MCNA's approval for commercial use in the US. Correct the majority of those treating bladder cancer patients heard the arguments for and against and voted yes

That was on top of several other Urologists who authored an article in the Journal of Urology a few months prior to that, that suggested it was approvable as a treatment. that was in addition to major US, French and SK Pharma companies that invested in its future over the past decade. so how did it wind up at worthless? How did this shareholder owned asset go from the FDA needs another P3 to valued at worthless? i think that the fairness committee must have interviewed all or at least some of the people who worked with MCNA and supported its approval before they agreed to the value of Worthless dont you?

The CEO mentioned in the swap release that PLI might reinvestigate this worthless MCNA thing at some point. You think so do ya? I think that it will be a partnered product inside of 12 months and on its way to market inside of 4 years once they get around to that investigation.

<< Previous
Bullboard Posts
Next >>